Origin: Sodium Hyaluronate is produced at HTL Biotechnology by fermentation with a Streptococcus equi natural strain (Group C of the Lancefield Classification / Non GMO / No material from animal origin). HTL’s proprietary process allows the production of Sodium Hyaluronate fiber with an exceptionally low level of impurities. HTL Sodium Hyaluronate raw material is a medical grade pharmaceutical product manufactured under cGMP conditions and is covered by a Certificate of Suitability of Monographs of the European Pharmacopoeia (CEP) and Drug Master File (DMF).
Background: Sodium hyaluronate is the sodium salt of hyaluronic acid (HA), a glycosaminoglycan consisting of D-glucuronic acid and N-acetyl-D-glucosamine disaccharide units. HA is one of several glycosaminoglycan components of the extracellular matrix of connective tissue. HA is a naturally occurring biopolymer involved in numerous biological processes including tissue hydration and structural scaffolding. HA is increasingly used and investigated in medical, pharmaceutical and bioengineering applications (for example in hydrogels for use in aesthetics, ophthalmology, rheumatology, urology, wound healing, 3D bioprinting, etc.). The methacrylated hyaluronate is photo-crosslinkable and can be used for generating hydrogel.
